Strategic Expansion European CDMO growth with recent FizzyBits launch and Vitafoods Europe 2026 presence signals a scaling opportunity to cross-sell new delivery formats and ingredient innovations to nutraceutical brands across Europe.

New Product Lines Launches of LifeChews and high-potency supplement solutions indicate a readiness to tailor contracts for finished dosage forms and potent blends, presenting upsell potential to existing pharma and supplement clients seeking advanced formats.

Habit-first Platform Introducing a habit-first longevity platform creates a consultative selling angle for lifestyle-focused brands and functional health products, enabling collaboration on ongoing product iterations, consumer engagement strategies, and long-term contracts.

Joint Health Focus Active development in iron, magnesium, and metabolic/joint health segments via FizzyBits and gummy portfolios suggests targeting brands in hematology, nutrition, and wellness spaces with contract manufacturing and formulation partnerships.

Industry Visibility Regular participation in CPHI, Vitafoods, and industry media coverage enhances credibility for outbound efforts, making it easier to introduce SIRIO Europe as a trusted European CDMO for nutraceutical and pharmaceutical clients seeking scalable manufacturing.